Lipopolysaccharide and interferon gamma activate nuclear factor kappa B and induce cyclo-oxygenase-2 in equine vascular smooth muscle cells.

This research study explores how bacterial lipopolysaccharide and human interferon impact equine vascular smooth muscle cells, with a focus on the roles of cyclooxygenase-2 and nuclear factor kappa B.

Objective of the Research

• The main aim of this research was to understand how bacterial byproduct lipopolysaccharide (LPS) and a type of signaling protein, human interferon (hIFN)-gamma, interact with equine vascular smooth muscle cells, and the subsequent biological ramifications. This research was done in the context of equine endotoxaemia, a fatal condition in horses caused due to bacterial toxins in the bloodstream.

Methods Used in the Research

• The researchers isolated equine vascular smooth muscle from various vessels and exposed them to LPS and hIFN-gamma. This was undertaken to study the effects on cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), two important enzymes in the body.
• The testing included reverse transcriptase polymerase chain reaction (rt-PCR) and Western blot analysis to ascertain the level of COX-2 expression and iNOS expression in the cell.

Findings of the Research

• The research revealed that COX-2 is actively expressed in equine vascular smooth muscle, with the cells producing prostaglandin E2—a type of fatty acid—in response to the interaction with LPS and hIFN-gamma.
• Conversely, the study discovered limited expression of iNOS in just one vascular smooth muscle preparation.
• The researchers observed that LPS and IFNgamma caused the translocation of the nuclear factor kappa B (NfkappaB)—a protein complex that plays a crucial role in cellular responses—to the nucleus in the equine cells, which indicates that the limited iNOS production observed in the studied cells is not due to deficits in the signal transduction pathway.

Conclusion of the Research

• Based on the results, the researchers concluded that in equine vascular smooth muscle, COX-2 and NfkappaB likely play pivotal roles in the development of equine endotoxaemia. This could imply potential pathways for therapeutic intervention in managing this condition.